Electrosurgical devices global Market estimated to be worth $6,635.6 million by 2027
Electrosurgery procedures employ devices where electrical energy is used to achieve a desired clinical effect in which a high radio-frequency (RF) 100 kHz to 5 MHz, alternating current at various voltage ranging from 200-10,000V is passed through the biological tissues to cut, coagulate, desiccate, or even to fuse tissue. Even though electrical devices are used for the cauterization of tissue in some applications like cardiology, cosmetic and dermatology, oncology, gynecology, gastrointestinal, urology, neurology and other laparoscopic surgeries, electrosurgery is considered as a quite different method than electrocautery as they utilize heat conduction from a probe heated by a direct current. The main advantage of using electrosurgical devices over electrocautery devices is that they reduce damage to the surrounding tissues as these devices are highly precise where the low voltage is preferred for cut modes and a high voltage is preferred for coagulation mode.
According to IQ4I analysis, the electrosurgical devices global market is to reach $6,635.6 million by 2027. An increase in the adoption of minimally invasive surgeries, rapid growth in the aging population, growing number of cosmetic surgeries, the prevalence of obesity and its related surgeries, the advancement in technology, and demand for electrosurgical procedures in emerging regions are driving the growth of the electrosurgical devices global market. However, the risk of side effects, rising incidence of product recalls, preference for non-invasive procedures, healthcare reforms especially government pressure to minimize healthcare costs and pricing pressure on device manufacturers are restraining the growth of electrosurgical devices global market.
The electrosurgery devices market is segmented based on products, application, end-user and geography. Among the electrosurgical products, instrument/units accounted for the largest share of XX% in 2020 generating revenue of $XX million and is expected to grow at a mid single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027. In the electrosurgical instruments market, the bipolar instruments segment accounted for the largest share of XX% in 2020 generating revenue of $XX million and is expected to grow at a high single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027. The bipolar instruments are preferred over monopolar instruments as it overcomes the risks associated with monopolar. Monopolar instruments are sub-segmented into contact monopolar and non-contact monopolar (plasma), among these, contact monopolar accounted for the largest share of XX% with the revenue of $XX million in 2020, non-contact monopolar (plasma) is expected to grow at a high single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027 due to their advantages such as no adhesion of coagulated tissue, fast, effective and homogenous coagulation and minimal smoke generation. Contact monopolar instruments are further segmented into electrosurgical electrodes, electrosurgical pencils, suction coagulators & irrigation devices and others, among these, electrosurgical pencils accounted for the largest share of XX% with a revenue of $XX million in 2020 and is expected to grow at a mid single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027. Bipolar electrosurgical instruments are segmented into vessel sealing devices and bipolar forceps, vessel sealing devices accounted for the largest share of XX% with a revenue of $XX million in 2020 and is expected to grow at a high single digit CAGR of XX% from 2020 to 2027. The rising demand for reliable and efficient technologies during surgeries to decrease blood loss and infections and to reduce operative time is one of the major reasons for the market growth.
Among application, oncology accounted for the largest share of XX% in 2020 generating revenue of $XX million in 2020 and is expected to reach $XX million by 2027 growing at a high single digit CAGR of XX% from 2020 to 2027 due to the increase in the number of cancer surgeries, rising awareness and growing adoption rate of electrosurgical devices during surgery. Based on end-user, the market is segmented into hospitals, ambulatory surgical centers and clinics, among these, the hospitals segment accounted for the largest share of XX% in 2020 generating revenue of $XX million and is expected to grow at a mid single digit CAGR of XX% from 2020 to 2027, availability of experienced and trained staff, better infrastructure and improved patient outcome are some of the advantages of the hospital for market growth. The ambulatory surgical centers' segment is expected to grow at a high single digit CAGR of XX% from 2020 to 2027, awareness among the people about ASC’s and its services, improved patient safety with cost-effective care are the factors that drive the ambulatory surgical center market.
In the electrosurgical devices global market based on geography, the North American region accounted for the largest share of XX% in 2020 generating revenue of $XX million and is expected to grow at a mid single digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027, due to the availability of highly advanced healthcare facilities, growing awareness about the technological advancements, availability of Medicare and third-party insurance facilities and easy availability of skilled personnel. Asia-pacific is the fastest-growing region and is expected to grow at the double digit CAGR of XX% from 2020 to 2027 to reach $XX million by 2027 due to increase in healthcare spending, advancements in healthcare facilities, and a growing number of health insurers.
Technological advancements and new product launches are mainly observed in this market such as the launch of Advanced Voyant Intelligent Energy System by Applied Medical Corporation in October 2020, The Voyant system has the unique ability to accelerate learning through user experience. The system’s intelligence is embedded in the device key to store activation data from each vessel or tissue bundle sealed during the surgical procedure. Data extracted from surgeries is analyzed by Applied Medical to produce new algorithms to meet ever-changing healthcare needs. The newest algorithm offers multiple benefits to surgeons, including excellent hemostasis, faster sealing times, and an overall reduction in tissue adherence. In May 2020, Olympus Corporation launched ESG-150 Electrosurgery Generator (ESG-150). The new ESG-150 possesses features that enhance patient safety and ease of use, the pillars on which the ESG-150 has been designed.
The electrosurgical market is highly consolidated where major players are securing their position through multiple mergers & acquisitions, expansions, deals, agreements and new product approvals to expand their portfolios. For instance, in August 2020, Hologic, Inc. acquired Acessa Health Inc. a privately-held innovator in minimally invasive treatment for fibroids. In July 2020, BiPad Surgical, Inc. received FDA approval for BiPAD Hand Activated, Disposable Bipolar electrocautery cords which is designed as an accessory to electrosurgical instruments where bipolar electrosurgical coagulation is desired during surgery. The top seven companies such as Medtronic PLC, Johnson & Johnson (Ethicon), B.Braun, Smiths & Nephew, Erbe Elektromedizin GmbH, Olympus Corporation, CONMED Corporation occupies XX% share of the overall electrosurgical market, among these, Medtronic occupies the largest share of XX% in 2020. Johnson & Johnson (Ethicon) held the top places in filing of PCT applications followed by Olympus Corporation and Medtronic PLC. which indicates their international outlook and value that these companies add to important technology and protect their IPR interests in potential markets.
According to IQ4I analysis, in 2020, the number of hospitals globally was estimated to be 123,794 with 463,636 operation theatre, where an estimated 239.7 million surgical procedure were performed, among these, the total number of surgical procedures done with electrosurgery including robotics in 2020 was 62.2 million, among these, XX million were gynecology surgeries, XX million were cancer-related surgeries, XX million were orthopedic-related surgeries, 12.8 million were laparoscopic surgeries, XX million were urology-related, XX million were cosmetic & dermatology surgeries, XX million were cardiovascular surgeries, XX million were neurology-related surgeries and XX million were other surgeries. Due to the impact of COVID-19, there was a slight dip in surgical procedures in 2020, for instance, in 2019 there were 77.6 million surgeries performed, whereas in 2020 only 62.2 million surgeries were performed with a 20.0% reduction.
Some of the major companies operating in the electrosurgical devices market are Braun Melsungen AG (Germany), Apyx Medical Corporation (U.S.), Bowa Electronic GmbH & Co. KG (Germany), CONMED Corporation (U.S.), Medtronic, PLC (Ireland), Erbe Electromedizin GmbH (Germany), Johnson & Johnson (Ethicon) (U.S.), Olympus Corporation (Japan), Smith & Nephew PLC (U.K.), Utah Medical Products Inc. (U.S.), Applied Medical Resources Corporation (U.S.), Boston Scientific Corporation (U.S.), Karl Storz SE & Co. KG (Germany), Arthrex Inc., (U.S.), Stryker Corporation (U.S.), Cooper Companies, Inc., (U.S.), Richard Wolf GmbH (Germany) and KLS Martin Group, (Germany).
Some of the emerging players in electrosurgical devices are ÜZÜMCÜ Medical Equipment (Turkey), Telea electronics engineering (Italy), Olives (India), Atricure Inc., (U.S.), Kirwan Surgical Products, LLC (U.S.), Encision Inc. (U.S.), Wisap medical technology (Germany), and Maxer Endoscopy (Germany).